ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $131,000 | +125.9% | 90,000 | +193.7% | 0.00% | – |
| Q4 2015 | $58,000 | -23.7% | 30,639 | +86.8% | 0.00% | – |
| Q2 2015 | $76,000 | -77.0% | 16,400 | -78.4% | 0.00% | -100.0% |
| Q1 2015 | $331,000 | +394.0% | 75,858 | +291.0% | 0.00% | +100.0% |
| Q4 2014 | $67,000 | -68.1% | 19,400 | -61.3% | 0.00% | -50.0% |
| Q3 2014 | $210,000 | +3.4% | 50,129 | +44.7% | 0.00% | -33.3% |
| Q2 2014 | $203,000 | – | 34,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |